VIRACEPT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Viracept, and when can generic versions of Viracept launch?
Viracept is a drug marketed by Agouron Pharms and is included in three NDAs.
The generic ingredient in VIRACEPT is nelfinavir mesylate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nelfinavir mesylate profile page.
Summary for VIRACEPT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 43 |
Patent Applications: | 3,843 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VIRACEPT |
What excipients (inactive ingredients) are in VIRACEPT? | VIRACEPT excipients list |
DailyMed Link: | VIRACEPT at DailyMed |
Recent Clinical Trials for VIRACEPT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 1 |
The University of Texas Health Science Center, Houston | Phase 2 |
Joseph Anthony Lucci III | Phase 2 |
Pharmacology for VIRACEPT
Drug Class | Protease Inhibitor |
Mechanism of Action | Cytochrome P450 3A Inhibitors HIV Protease Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for VIRACEPT
US Patents and Regulatory Information for VIRACEPT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 020779-001 | Mar 14, 1997 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VIRACEPT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 020779-001 | Mar 14, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VIRACEPT
See the table below for patents covering VIRACEPT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Georgia, Republic of | P20002209 | HIV Protease Inhibitors | ⤷ Try a Trial |
African Intellectual Property Organization (OAPI) | 10718 | Hiv protease inhibitors | ⤷ Try a Trial |
Germany | 69434977 | ⤷ Try a Trial | |
Czech Republic | 9601004 | ⤷ Try a Trial | |
Canada | 2112052 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |